Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

EGFR amplification and lack of activating mutations in metaplastic breast carcinomas.

Reis-Filho JS, Pinheiro C, Lambros MB, Milanezi F, Carvalho S, Savage K, Simpson PT, Jones C, Swift S, Mackay A, Reis RM, Hornick JL, Pereira EM, Baltazar F, Fletcher CD, Ashworth A, Lakhani SR, Schmitt FC.

J Pathol. 2006 Aug;209(4):445-53.

PMID:
16739104
3.

Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis.

Reis-Filho JS, Milanezi F, Carvalho S, Simpson PT, Steele D, Savage K, Lambros MB, Pereira EM, Nesland JM, Lakhani SR, Schmitt FC.

Breast Cancer Res. 2005;7(6):R1028-35. Epub 2005 Oct 25.

4.

Association of epidermal growth factor receptor (EGFR) gene copy number amplification with neck lymph node metastasis in areca-associated oral carcinomas.

Chiang WF, Liu SY, Yen CY, Lin CN, Chen YC, Lin SC, Chang KW.

Oral Oncol. 2008 Mar;44(3):270-6. Epub 2007 Apr 30.

PMID:
17468034
5.

Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.

Chung CH, Ely K, McGavran L, Varella-Garcia M, Parker J, Parker N, Jarrett C, Carter J, Murphy BA, Netterville J, Burkey BB, Sinard R, Cmelak A, Levy S, Yarbrough WG, Slebos RJ, Hirsch FR.

J Clin Oncol. 2006 Sep 1;24(25):4170-6.

PMID:
16943533
6.

Epidermal growth factor receptor structural alterations in gastric cancer.

Moutinho C, Mateus AR, Milanezi F, Carneiro F, Seruca R, Suriano G.

BMC Cancer. 2008 Jan 16;8:10. doi: 10.1186/1471-2407-8-10.

7.

Decreased survival in EGFR gene amplified vulvar carcinoma.

Growdon WB, Boisvert SL, Akhavanfard S, Oliva E, Dias-Santagata DC, Kojiro S, Horowitz NS, Iafrate AJ, Borger DR, Rueda BR.

Gynecol Oncol. 2008 Nov;111(2):289-97. doi: 10.1016/j.ygyno.2008.07.038. Epub 2008 Sep 3.

PMID:
18768215
8.

Chromosome 7 aneusomy in metaplastic breast carcinomas with chondroid, squamous, and spindle-cell differentiation.

Gwin K, Lezon-Geyda K, Harris L, Tavassoli FA.

Int J Surg Pathol. 2011 Feb;19(1):20-5. doi: 10.1177/1066896909334127. Epub 2009 May 1.

PMID:
19411277
9.
10.

Epithelioid sarcoma expresses epidermal growth factor receptor but gene amplification and kinase domain mutations are rare.

Cascio MJ, O'Donnell RJ, Horvai AE.

Mod Pathol. 2010 Apr;23(4):574-80. doi: 10.1038/modpathol.2010.2. Epub 2010 Jan 29.

11.

EGFR gene copy number increase in vulvar carcinomas is linked with poor clinical outcome.

Woelber L, Hess S, Bohlken H, Tennstedt P, Eulenburg C, Simon R, Gieseking F, Jaenicke F, Mahner S, Choschzick M.

J Clin Pathol. 2012 Feb;65(2):133-9. doi: 10.1136/jcp-2010-079806. Epub 2011 Nov 29.

PMID:
22128196
12.

Validation of chromogenic in situ hybridization for detection of EGFR copy number amplification in nonsmall cell lung carcinoma.

Sholl LM, John Iafrate A, Chou YP, Wu MT, Goan YG, Su L, Huang YT, Christiani DC, Chirieac LR.

Mod Pathol. 2007 Oct;20(10):1028-35. Epub 2007 Aug 3.

13.
14.

FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis.

Elbauomy Elsheikh S, Green AR, Lambros MB, Turner NC, Grainge MJ, Powe D, Ellis IO, Reis-Filho JS.

Breast Cancer Res. 2007;9(2):R23.

15.

EGFR expression and gene copy number in triple-negative breast carcinoma.

Gumuskaya B, Alper M, Hucumenoglu S, Altundag K, Uner A, Guler G.

Cancer Genet Cytogenet. 2010 Dec;203(2):222-9. doi: 10.1016/j.cancergencyto.2010.07.118.

PMID:
21156237
16.

Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas.

Geyer FC, Weigelt B, Natrajan R, Lambros MB, de Biase D, Vatcheva R, Savage K, Mackay A, Ashworth A, Reis-Filho JS.

J Pathol. 2010 Apr;220(5):562-73. doi: 10.1002/path.2675.

PMID:
20099298
17.

Combined genomic and gene expression microarray profiling identifies ECOP as an upregulated gene in squamous cell carcinomas independent of DNA amplification.

Baras A, Yu Y, Filtz M, Kim B, Moskaluk CA.

Oncogene. 2009 Aug 13;28(32):2919-24. doi: 10.1038/onc.2009.150. Epub 2009 Jun 15.

PMID:
19525979
18.

EGFR gene amplification is related to adverse clinical outcomes in cervical squamous cell carcinoma, making the EGFR pathway a novel therapeutic target.

Iida K, Nakayama K, Rahman MT, Rahman M, Ishikawa M, Katagiri A, Yeasmin S, Otsuki Y, Kobayashi H, Nakayama S, Miyazaki K.

Br J Cancer. 2011 Jul 26;105(3):420-7. doi: 10.1038/bjc.2011.222. Epub 2011 Jul 5.

19.

Genomic and immunohistochemical analysis of adenosquamous carcinoma of the breast.

Geyer FC, Lambros MB, Natrajan R, Mehta R, Mackay A, Savage K, Parry S, Ashworth A, Badve S, Reis-Filho JS.

Mod Pathol. 2010 Jul;23(7):951-60. doi: 10.1038/modpathol.2010.82. Epub 2010 May 7.

20.

May metaplastic breast carcinomas be actually basal-like carcinoma? Further evidence study with its ultrastructure and survival analysis.

Wang H, Guan B, Shi Q, Ma H, Zhou H, Wang X, Zhou X.

Med Oncol. 2011 Mar;28(1):42-50. doi: 10.1007/s12032-009-9399-1. Epub 2009 Dec 30.

PMID:
20041316

Supplemental Content

Support Center